Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)
Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)
Enrolling by invitation · NCT07221565 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT) | CNS demyelinating autoimmune disease, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, autoimmune disorder of the nervous system, connective tissue disorder, demyelinating disease, immune system disorder, multiple sclerosis, musculoskeletal system disorder, nervous system disorder, rheumatic disorder, rheumatoid arthritis, systemic lupus erythematosus | Enrolling by invitation | Phase 1 / Phase 2 | 2026-05-22 | NCT07221565 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Truway Health, Inc. | 16 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Truway Health, Inc. www.truwayhealth.com (401 E 34th Street, S11P, New York, NY 10016) | New York | United States | 1 |